StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Total U.S. Industry FDA PMA & Supplements Approvals by Year

Total U.S. Industry FDA PMA & Supplements Approvals (U.S. Industry Total)

Thermo Fisher Scientific Total U.S. Industry FDA PMA & Supplements Approvals: 2,222 in FY2025, down 0.4% from a year earlier.

Latest, FY2025
2,222
Period ended Dec 31, 2025
Change on a year earlier
-0.4%
2,230 in FY2024
History
10 years
Since FY2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total

Where the FY2025 figure comes from

Source: openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗

Reported in U.S. FDA openFDA Premarket Approval (PMA) API.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Thermo Fisher Scientific Total U.S. Industry FDA PMA & Supplements Approvals, annual FY2016–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-pma-industry

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.